NCT02113163View on ClinicalTrials.gov

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions

Diabetes Mellitus, Non-Insulin-DependentHypertriglyceridemia

Interventions

DRUG

Metformin Eicosapentaenoate

DRUG

Metformin HCl and Vascepa

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors

lead

Thetis Pharmaceuticals LLC

INDUSTRY

NCT02113163 - PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA | Biotech Hunter | Biotech Hunter